Iranian Journal of Reproductive Medicine最新文献

{"title":"The association between single nucleotide polymorphism in interleukin-27 gene and recurrent pregnancy loss in Iranian women.","authors":"Zeinab Nematollahi,&nbsp;Hossein Hadinedoushan,&nbsp;Abbas Aflatoonian,&nbsp;Gilda Eslami,&nbsp;Nasrin Ghasemi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Recurrent pregnancy loss (RPL) has been defined as two or more miscarriages before 20(th) week of gestation. It seems that IL-27 may reduce inflammatory responses and affect the survival of the embryo during human pregnancy. IL-27 polymorphisms may influence RPL by altering the levels or the activity of gene product.</p><p><strong>Objective: </strong>We studied for the first time the association of IL-27 -964 A>G single nucleotide polymorphism (SNP) with RPL in Iranian women.</p><p><strong>Materials and methods: </strong>A case-controlled study was performed on two groups consisting of 150 healthy women with at least one delivery (control group) and 150 women with two or more primary RPLs history (RPL group). The -964 A>G SNP in IL-27 gene was determined by PCR-RFLP technique. Genotype and allele frequencies were compared using (2) tests between two groups.</p><p><strong>Results: </strong>There was no difference between the two groups regarding age of women (29±4.4 [control] vs. 30.84±5.2 years [case]). In the RPL group, the genotype frequencies of -964 A>G polymorphism were AG (49.3%), AA (40%), and GG (10.7%), and in the control group, they were AG (43.3%), AA (48.7%), and GG (8%). There was no significant difference between the genotypes of AA, AG, and GG in two groups (p=0.23). As the frequency of allele A was 64.7% in the RPL group and 70.3% in the control group, the difference in frequency of allele A in -964 A>G between two groups was not significant (p=0.19).</p><p><strong>Conclusion: </strong>Our findings indicate that SNP of -964 A>G in IL-27 gene is not a risk factor for RPL in Iranian women.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"209-14"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33868439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SULF 1 gene polymorphism, rs6990375 is in significant association with fetus failure in IVF technique.","authors":"Eskandar Taghizadeh,&nbsp;Seyed Mehdi Kalantar,&nbsp;Reza Mahdian,&nbsp;Mohammad Hasan Sheikhha,&nbsp;Ehsan Farashahi-Yazd,&nbsp;Saeed Ghasemi,&nbsp;Zahra Shahbazi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Sulfatase 1 (SULF1) function is to remove the 6-O-sulphate group from heparan sulfate. This action changes the binding sites of extracellular growth factors. SULF1 expression has been reported to be changed in angiogenesis. We hypothesized that single nucleotide polymorphisms (SNPs) of SULF1 would impact clinicopathologic characteristics.</p><p><strong>Objective: </strong>Study of SULF1 gene polymorphism with fetus failure in in vitro fertilization (IVF) technique.</p><p><strong>Materials and methods: </strong>We studied one common (minor allele frequency >0.05) regulatory SNP, rs6990375, with polymerase chain reaction and restriction fragment length polymorphism method, in 53 infertile women with fetus failure in IVF technique and 53 women with at least one healthy child as controls.</p><p><strong>Results: </strong>We found that rs6990375 is significantly associated with an early failure in IVF and frequency of G allele is high in women with fetus failure in IVF technique (p<0.001).</p><p><strong>Conclusion: </strong>These findings suggest that SULF1genetic variations may play a role in IVF technique fetus failure. Further studies with large sample sizes on SULF1 SNPs may be useful in support of this claim.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"215-20"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33868440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Granulocyte colony-stimulating factor and reproductive medicine: A review.","authors":"Marcelo Borges Cavalcante,&nbsp;Fabrício DA Silva Costa,&nbsp;Ricardo Barini,&nbsp;E Araujo Júnior","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Recently, the use of granulocyte colony-stimulating factor (G-CSF) has been proposed to improve pregnancy outcomes in reproductive medicine.</p><p><strong>Objective: </strong>A systematic review of the current use of G-CSF in patients who have difficulty conceiving and maintaining pregnancy was performed.</p><p><strong>Materials and methods: </strong>Two electronic databases (PubMed/ Medline and Scopus) were searched. Study selection, data extraction and quality assessment were performed in duplicate. The subject codes used were granulocyte colony-stimulating factor, G-CSF, recurrent miscarriage, IVF failure, and endometrium.</p><p><strong>Results: </strong>The search of electronic databases resulted in 215 citations (PubMed/ Medline: 139 and Scopus: 76), of which 38 were present in both databases. Of the remaining 177 publications, seven studies were included in the present review.</p><p><strong>Conclusion: </strong>Treatment with G-CSF is a novel proposal for immune therapy in patients with recurrent miscarriage and implantation failure following cycles of IVF. However, a larger number of well-designed studies are required for this treatment to be established.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"195-202"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33868437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of serum 25-hydroxy vitamin D levels between mothers with small for gestational age and appropriate for gestational age newborns in Kerman.","authors":"Fatemeh Mirzaei,&nbsp;Tayebeh Amiri Moghadam,&nbsp;Peyman Arasteh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Vitamin D deficiency during pregnancy is associated with some adverse pregnancy outcomes but its relationship with fetal growth is unknown.</p><p><strong>Objective: </strong>We compared the 25-hydroxy vitamin D levels between mothers and their small for gestational age (SGA) newborns with mothers and their appropriate for gestational age (AGA) newborns.</p><p><strong>Materials and methods: </strong>The study population included pregnant women that referred to Afzalipour Hospital in Kerman from 2012 to 2013. The case and control group consisted of 40 pregnant mothers with SGA and AGA newborns, respectively. The maternal and infants 25-hydroxy vitamin D levels were measured in the two groups.</p><p><strong>Results: </strong>25-hydroxy vitamin D deficiency (<20 ng/ml) was statistically higher in women with SGA newborns in comparison to women with AGA newborns (p=0.003).Vitamin D deficiency was higher among the SGA newborns in comparison to AGA newborns (25% vs. 17.5%), although this finding was not statistically meaningful (p=0.379). The relationship of vitamin D deficiency levels between mothers and infants in both the SGA group and the AGA group was significant.</p><p><strong>Conclusion: </strong>Our study reveals a high prevalence of vitamin D deficiency in women with SGA infants in comparison to women with AGA children. In addition, maternal vitamin D deficiency is associated with its deficiency in newborns.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"203-8"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475768/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33868438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI.","authors":"Gültekin Adanaş Aydın,&nbsp;Arzu Yavuz,&nbsp;Hasan Terzi,&nbsp;Tayfun Kutlu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Anti-Mullerian hormone (AMH) is constantly secreted during menstrual cycles and may offer several advantages over traditional biomarkers of ovarian reserve.</p><p><strong>Objective: </strong>To assess the relationship of anti-Mullerian hormone (AMH) values, which are used to evaluate ovary reserves, with oocyte and embryo quality and with ART outcomes in patients undergoing intra-cytoplasmic sperm injection (ICSI).</p><p><strong>Materials and methods: </strong>This cross sectional study was performed using 50 women undergoing ICSI in IVF center of Zeynep Kamil Women's and Children's Hospital, İstanbul, Turkey. All patients received the long protocol. Follicle-stimulating hormone, luteinizing hormone, estradiol, and AMH levels were measured and antral follicle counts were obtained on the 3(rd) day of menstruation. A cut-off value based on the number of oocytes was determined for AMH, and women were evaluated after being divided into two groups as bad responders and good responders, according to their AMH levels.</p><p><strong>Results: </strong>Twelve (27.3%) women were in bad responders group and 32 (72.7%) women were in good responders group. AMH measurements were statistically significantly different between the two groups (p<0.01). Based on this significance, the researchers used ROC analysis to estimate a cut-off point for AMH. The researchers detected the good responders with an AMH level 1.90 or above, with 87.50% sensitivity, 66.67% specificity, 87.50% positive prediction, and 66.67% negative prediction (AUC=0.777, p<0.01).</p><p><strong>Conclusion: </strong>Basal AMH levels can be used as an indicator to determine the ovarian response in women undergoing ICSI. AMH can be used to predict the number of mature oocytes that can be collected during treatment and the number of oocytes that can be fertilized. However, AMH is not a valuable tool to evaluate oocyte quality, the development of high-quality embryos, or pregnancy conception.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"231-6"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34248845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders.","authors":"Mesut Yıldız,&nbsp;Mehmet Vural,&nbsp;Mehmet Emin Erdal,&nbsp;Özlem İzci Ay,&nbsp;Şenay Görücü Yılmaz,&nbsp;İbrahim Fatih Karababa,&nbsp;Salih Selek","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Premenstrual dysphoric disorder (PMDD) is a mood disorder characterized with physical and affective symptoms during the luteal phase of susceptible women.</p><p><strong>Objective: </strong>The aim of this study was to investigate the association of Dopamine D3 receptor (DRD3) polymorphism, and Cannabinoid receptor Type 1 (CNR1) polymorphism with PMDD.</p><p><strong>Materials and methods: </strong>Fifty one participants with documented PMDD according to the DSM IV criteria and 51 healthy controls were included in this cross sectional study. Symptom severity was measured with daily self-rating, monthly premenstrual assessment forms and psychiatric interviews. The genotyping of DRD3 receptor and Cannabinoid type 1 receptors were performed using Taqmanfluorogenic assay method.</p><p><strong>Results: </strong>Distribution of DRD3 and CNR1 polymorphism was not different between patients and controls.</p><p><strong>Conclusion: </strong>These findings do not support a major role of DRD3, and CNR1 polymorphisms in contributing to susceptibility to premenstrual dysphoric disorder.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"221-6"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33868441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis.","authors":"Shahrzad Zadehmodarres,&nbsp;Zahra Heidar,&nbsp;Zahra Razzaghi,&nbsp;Leili Ebrahimi,&nbsp;Kaveh Soltanzadeh,&nbsp;Farhang Abed","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovarian syndrome (PCOS) is a common endocrinopathy that accompanied with long term complications. The early diagnosis of this syndrome can prevent it.</p><p><strong>Objective: </strong>The aim was to determine the role of anti-mullerian hormon (AMH) in PCOS diagnosis and to find cut off level of it.</p><p><strong>Materials and methods: </strong>In this cross sectional study, 117 women between 20-40 years old were participated in two groups: 60 PCOS women (based on Rotterdam criteria consensus) as the case group and 57 normal ovulatory women as the control group. In day 2-4 of cycle, transvaginal sonography was performed and serum hormonal level of AMH, luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E2), testosterone, fasting blood sugar (FBS), thyroid stimulating hormone (TSH), and prolactin (PRL) were measured in all of participants. For all of them score of hirsutism (base on Freeman-Galloway scoring) was determined.</p><p><strong>Results: </strong>There were statistically significant in irregular pattern of menstruation, AMH and FSH level, and presence of hirsutism between two groups. But regarding mean of age, body mass index, plasma level of PRL, TSH, LH, Testosterone, FBS, and E2 differences were not significant. Construction by ROC curve present 3.15 ng/ml as AMH cut off with 70.37% sensitivity and 77.36% specificity in order to PCOS diagnosis.</p><p><strong>Conclusion: </strong>AMH with cut off level of 3.15 ng/ml with sensitivity 70.37% and specificity 77.36% could use for early diagnosis of PCOS patients.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 4","pages":"227-30"},"PeriodicalIF":0.0,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34248844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Types of reproductive disorders in underweight and overweight young females and correlations of respective hormonal changes with BMI.","authors":"Nutsa Aladashvili-Chikvaidze,&nbsp;Jenara Kristesashvili,&nbsp;Manana Gegechkori","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Higher risks of reproductive problems have been found in underweight and overweight women with rapid weight gain or loss but evidence is inconsistent especially in relation to the effect of age of body weight changes.</p><p><strong>Objective: </strong>The aim of our study was to detect the peculiarities of menstrual function, prevalence of different types of reproductive disorders and correlations of respective hormonal changes with body mass index (BMI) in young female patients with thinness or obesity since childhood.</p><p><strong>Materials and methods: </strong>In this prospective cross-sectional study 48 underweight and 55 overweight/obese young women with different reproductive problems underwent complete clinical and hormonal analyses. All 103 patients had weight problems since childhood.</p><p><strong>Results: </strong>Polycystic ovarian syndrome and metabolic syndrome was the most frequent in overweight and obese women, whilst non-classical congenital adrenal hyperplasia and ovarian dysfunction prevailed in underweight women (p˂0.001). No difference was determined according to the age of menarche (p=0.885) and types of menstrual disturbances (p=0.34) between the study groups. Hypogonadotropic hypogonadism was not found in young women who were lean since childhood. Follicle-stimulating hormone (FSH) (p=0.013) and sex hormone binging globulin (SHBG) (p˂0.001) levels were higher in women with low BMI, whilst free testosterone (FT) (p=0.019) and total testosterone (TT) (p=0.003) levels were higher in high BMI participants. BMI negatively correlated with FSH (p=0.009) and SHBG (p=0.001); and positively correlated with FT (p=0.001) and TT (p=0.002).</p><p><strong>Conclusion: </strong>Peculiarities of menstrual function and hormonal changes in young women with thinness or obesity since childhood are related to the types of reproductive disorders and their childhood BMI.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 3","pages":"135-40"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33200367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of assisted reproductive technology with adverse pregnancy outcomes.","authors":"Zhang Jie, Ding Yiling, Yu Ling","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>More and more infertile patients have accepted the assisted reproductive technique (ART) therapy. Concerns have been raised over an increased risk of adverse maternal outcomes in ART populations as compared with natural conception (NC).</p><p><strong>Objective: </strong>The aim was to improve the ART in clinicial work and to reduce the incidence of pregnancy complications in ART group according to analyzing the reasons of high incidence of pregnancy complications in ART group, comparing the incidence of pregnancy complications in different controlled ovarian hyperstimulation (COH) programs and evaluating the effects of ART which attribute to adverse pregnancy outcomes.</p><p><strong>Materials and methods: </strong>In this prospective population-based cohort study,3216 pregnant women with gestational age ≤12 weeks, regular antenatal examination,and ultrasound identification of intrauterine pregnancy were enrolled from January 2010 to June 2013. According to having ART history, the participantswere divided into two groups: ART group (contains fresh embryo transfer group or frozen-thawed embryo transfer group) and NC group. We compared the incidence of pregnancy complications between different groups and evaluated the factors which could affect the occurrence of these complications.</p><p><strong>Results: </strong>When compared to NC group, significantly increased rates of gestational diabetes mellitus (GDM) (p<0.01), preeclampsia (PE) (p<0.01) and intrahepatic cholestasis of pregnancy (ICP) (p˂0.01) were observed in ART group. There was no significant difference in the incidence of birth defect between the two groups (p=0.07). Multiple pregnancies and Gonadotropin (Gn) were risk factors in GDM, PE, and ICP. The exogenous progesterone treatment had no effect on GDM, PE or ICP.</p><p><strong>Conclusion: </strong>ART increases the risk of adverse maternal complications such as GDM, PE and ICP. The dosages of Gn should be reduced to an extent and the number of embryo implantation should be controlled. Exogenous progesterone treatment is safe.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 3","pages":"169-80"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426157/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33200372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intrauterine synechiae after myomectomy; laparotomy versus laparoscopy: Non-randomized interventional trial.","authors":"Zahra Asgari,&nbsp;Leili Hafizi,&nbsp;Rayhaneh Hosseini,&nbsp;Atiyeh Javaheri,&nbsp;Hathis Rastad","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Leiomyomata is the most frequent gynecological neoplasm. One of the major complications of myomectomy is intrauterine adhesion (synechiae).</p><p><strong>Objective: </strong>To evaluate and compare the rate and severity of synechiae formation after myomectomy by laparotomy and laparoscopy.</p><p><strong>Materials and methods: </strong>In this non-randomized interventional trial, hysteroscopy was performed in all married fertile women who had undergone myomectomy (type 3-6 interamural and subserosal fibroids) via laparotomy and laparoscopy in Tehran's Arash Hospital from 2010 to 2013. Three months after the operation, the occurrence rate and severity of intrauterine synechiae, and its relationship with type, number and location of myomas were investigated and compared in both groups.</p><p><strong>Results: </strong>Forty patients (19 laparoscopy and 21 laparotomy cases) were studied. Both groups were similar regarding the size, type (subserosal or intramural), number and location of myoma. The occurrence rate of synechiae in the laparoscopy and laparotomy group was 21% and 19%, respectively; showing no significant difference (p=0.99). Among all patients, no significant relationship was found between the endometrial opening (p=0.92), location (p=0.14) and type of myoma (p=0.08) with the occurrence rate of synechiae. However, a significant relationship was observed between myoma's size (p=0.01) and the location of the largest myoma with the occurrence of synechiae (p=0.02).</p><p><strong>Conclusion: </strong>With favorable suturing methods, the outcome of intrauterine synechiae formation after myomectomy, either performed by laparotomy or laparoscopy, is similar. In all cases of myomectomy in reproductive-aged women, postoperative hysteroscopy is highly recommended to better screen intrauterine synechiae.</p>","PeriodicalId":14673,"journal":{"name":"Iranian Journal of Reproductive Medicine","volume":"13 3","pages":"161-8"},"PeriodicalIF":0.0,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33200371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}